James F Parslow insider trades

Open-market stock purchases and sales by James F Parslow, Interim CEO and CFO at Xenetic Biosciences, Inc, from SEC Form 4 filings since Sep 17, 2012.

Recent trades

DateStockTradeValue
Apr 21, 2026XBIO Xenetic Biosciences, IncBought (not open market)—

Companies traded

  • XBIO Xenetic Biosciences, Inc: other filings, last Apr 21, 2026
  • XWES World Energy Solutions, Inc: other filings, last Jan 5, 2015

Get free alerts when James F Parslow files a new trade →